These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1067052)

  • 21. Long-term therapy with deflazacort in chronic sarcoidosis.
    Rizzato G; Fraioli P; Montemurro L
    Chest; 1991 Feb; 99(2):301-9. PubMed ID: 1846572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The possible influence of corticosteroid therapy on the natural course of pulmonary sarcoidosis. Late results of a continuing clinical study.
    Eule H; Weinecke A; Roth I; Wuthe H
    Ann N Y Acad Sci; 1986; 465():695-701. PubMed ID: 3524366
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of gallium-67 scanning, bronchoalveolar lavage, and serum angiotensin-converting enzyme levels in pulmonary sarcoidosis. Predicting response to therapy.
    Baughman RP; Fernandez M; Bosken CH; Mantil J; Hurtubise P
    Am Rev Respir Dis; 1984 May; 129(5):676-81. PubMed ID: 6326626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of corticosteroid or methotrexate therapy on lung lymphocytes and macrophages in sarcoidosis.
    Baughman RP; Lower EE
    Am Rev Respir Dis; 1990 Dec; 142(6 Pt 1):1268-71. PubMed ID: 2252243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Signifance of diffusion capacity for the diagnosis of lung diseases].
    Bergstermann H; Emslander HP
    MMW Munch Med Wochenschr; 1974 Jan; 116(4):151-8. PubMed ID: 4206047
    [No Abstract]   [Full Text] [Related]  

  • 26. Corticosteroids for pulmonary sarcoidosis.
    Paramothayan NS; Jones PW
    Cochrane Database Syst Rev; 2000; (2):CD001114. PubMed ID: 10796598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Corticosteroid therapy of intrathoracic sarcoidosis stages I and II--results of a controlled clinical trial.
    Eule H; Roth I; Ehrke I; Weinecke W
    Z Erkr Atmungsorgane; 1977 Jul; 149(1):142-7. PubMed ID: 343403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exercise testing in pulmonary sarcoidosis.
    Matthews JI; Hooper RG
    Chest; 1983 Jan; 83(1):75-81. PubMed ID: 6848336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug therapy reviews: treatment of sarcoidosis.
    Fanburg BL
    Am J Hosp Pharm; 1979 Mar; 36(3):351-4. PubMed ID: 369368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lung function declines in patients with pulmonary sarcoidosis and increased respiratory epithelial permeability to 99mTc-DTPA.
    Chinet T; Dusser D; Labrune S; Collignon MA; Chrétien J; Huchon GJ
    Am Rev Respir Dis; 1990 Feb; 141(2):445-9. PubMed ID: 2405760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Course of pulmonary sarcoidosis with and without corticosteriod therapy as determined by pulmonary function studies.
    Sharma OP; Colp C; Williams MH
    Am J Med; 1966 Oct; 41(4):541-51. PubMed ID: 5923597
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pulmonary sarcoidosis and lung function (author's transl)].
    Specht H; Fruhmann G
    Prax Pneumol; 1974 Feb; 28(2):99-108. PubMed ID: 4832480
    [No Abstract]   [Full Text] [Related]  

  • 33. Increased levels of serum interferon-gamma in pulmonary sarcoidosis and relationship with response to corticosteroid therapy.
    Prior C; Haslam PL
    Am Rev Respir Dis; 1991 Jan; 143(1):53-60. PubMed ID: 1898846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Corticosteroid therapy of pulmonary sarcoidosis. A prospective evaluation of alternate day and daily dosage in stage II disease.
    Selroos O; Sellergren TL
    Scand J Respir Dis; 1979 Aug; 60(4):215-21. PubMed ID: 531541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of short-course, low-dose corticosteroid therapy for acute pulmonary sarcoidosis exacerbations.
    McKinzie BP; Bullington WM; Mazur JE; Judson MA
    Am J Med Sci; 2010 Jan; 339(1):1-4. PubMed ID: 19996733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. British Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment.
    Gibson GJ; Prescott RJ; Muers MF; Middleton WG; Mitchell DN; Connolly CK; Harrison BD
    Thorax; 1996 Mar; 51(3):238-47. PubMed ID: 8779124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Daily vs alternate day prednisone therapy for stage II sarcoidosis.
    Spratling L; Tenholder MF; Underwood GH; Feaster BL; Requa RK
    Chest; 1985 Nov; 88(5):687-90. PubMed ID: 4053710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulmonary function in stage I and II pulmonary sarcoidosis.
    Miller A; Chuang M; Teirstein AS; Siltzbach LE
    Ann N Y Acad Sci; 1976; 278():292-300. PubMed ID: 1067014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors of relapse in pulmonary sarcoidosis treated with corticosteroids.
    Zheng Y; Wang H; Xu Q; Yan X; Zhuang Y; Jiang H; Meng F; Xiao Y; Cai H; Dai J
    Clin Rheumatol; 2019 Jul; 38(7):1993-1999. PubMed ID: 30877493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolonged use of methotrexate for sarcoidosis.
    Lower EE; Baughman RP
    Arch Intern Med; 1995 Apr; 155(8):846-51. PubMed ID: 7717793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.